Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.
Apparent confined placental mosaicism of trisomy 16 and multiple fetal anomalies: case report.
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses.
Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53.
VAV3 mediates resistance to breast cancer endocrine therapy.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53.
Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53. Oncogene. 2003 Aug 28; 22(36):5586-91.
View in:
PubMed
subject areas
Apoptosis
Dual-Specificity Phosphatases
Humans
Mitogen-Activated Protein Kinases
Phosphorylation
Protein Tyrosine Phosphatases
Transcription, Genetic
Tumor Cells, Cultured
Tumor Suppressor Protein p53
authors with profiles
Yusuke Nakamura